Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://elifesciences.org/articles/43302, but it redirected us to https://elifesciences.org/articles/43302. The analysis below is for the second page.

Title[redir]:
Cell-based HTS identifies a chemical chaperone for preventing ER protein aggregation and proteotoxicity | eLife
Description:
Cell-based high-throughput screening identifies IBT21 as a chemical chaperone, that inhibits ER protein aggregation and prevents the cell death caused by a proteotoxin, the aggregation-prone prion protein.

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {πŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

πŸ™οΈ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 75,579,999 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We find it hard to spot revenue streams.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Doi.org could be secretly minting cash, but we can't detect the process.

Keywords {πŸ”}

figure, ibt, protein, proteins, chemical, supplement, stress, download, cell, cells, google, scholar, upr, japan, data, pubmed, chaperones, asset, medical, tokushima, compounds, institute, research, source, university, sciences, molecular, dataset, chaperone, aggregation, unfolded, usa, open, competing, interests, tokyo, misfolded, prion, activity, group, response, effects, reporter, atf, presence, analysis, disease, target, inhibition, activation,

Topics {βœ’οΈ}

xlsx download elife-43302-fig2-figsupp2-data1-v2 xlsx download elife-43302-fig2-figsupp1-data1-v2 xlsx download elife-43302-fig4-figsupp5-data1-v2 xlsx download elife-43302-fig4-figsupp4-data1-v2 xlsx download elife-43302-fig4-figsupp3-data1-v2 xlsx download elife-43302-fig4-figsupp2-data1-v2 xlsx download elife-43302-fig4-figsupp1-data1-v2 xlsx download elife-43302-fig1-figsupp1-data1-v2 xlsx download elife-43302-fig3-figsupp1-data1-v2 xlsx download elife-43302-fig5-figsupp1-data1-v2 xlsx download elife-43302-fig6-figsupp1-data1-v2 xlsx download elife-43302-fig5-figsupp1-data2-v2 xlsx download elife-43302-fig5-figsupp1-data3-v2 xlsx download elife-43302-fig6-figsupp1-data2-v2 xlsx download elife-43302-fig6-figsupp1-data3-v2 org/articles/43302/elife-43302-fig2-figsupp2-data1-v2 org/articles/43302/elife-43302-fig2-figsupp1-data1-v2 org/articles/43302/elife-43302-fig4-figsupp5-data1-v2 org/articles/43302/elife-43302-fig4-figsupp4-data1-v2 org/articles/43302/elife-43302-fig4-figsupp3-data1-v2 org/articles/43302/elife-43302-fig4-figsupp2-data1-v2 org/articles/43302/elife-43302-fig4-figsupp1-data1-v2 org/articles/43302/elife-43302-fig1-figsupp1-data1-v2 org/articles/43302/elife-43302-fig3-figsupp1-data1-v2 org/articles/43302/elife-43302-fig5-figsupp1-data1-v2 org/articles/43302/elife-43302-fig6-figsupp1-data1-v2 org/articles/43302/elife-43302-fig5-figsupp1-data2-v2 org/articles/43302/elife-43302-fig5-figsupp1-data3-v2 org/articles/43302/elife-43302-fig6-figsupp1-data2-v2 org/articles/43302/elife-43302-fig6-figsupp1-data3-v2 xlsx download elife-43302-fig4-data1-v2 xlsx download elife-43302-fig1-data1-v2 xlsx download elife-43302-fig3-data1-v2 xlsx download elife-43302-fig5-data1-v2 xlsx download elife-43302-fig6-data1-v2 xlsx download elife-43302-fig5-data2-v2 xlsx download elife-43302-fig5-data3-v2 xlsx download elife-43302-fig6-data2-v2 xlsx download elife-43302-fig6-data3-v2 xlsx download elife-43302-fig7-data1-v2 xlsx download elife-43302-fig5-data4-v2 xlsx download elife-43302-fig6-data4-v2 org/articles/43302/elife-43302-fig4-data1-v2 org/articles/43302/elife-43302-fig1-data1-v2 org/articles/43302/elife-43302-fig3-data1-v2 org/articles/43302/elife-43302-fig5-data1-v2 org/articles/43302/elife-43302-fig6-data1-v2 org/articles/43302/elife-43302-fig5-data2-v2 org/articles/43302/elife-43302-fig5-data3-v2 org/articles/43302/elife-43302-fig6-data2-v2

Schema {πŸ—ΊοΈ}

ScholarlyArticle:
      context:https://schema.org
      mainEntityOfPage:
         type:WebPage
         id:https://elifesciences.org/articles/43302
      headline:Cell-based HTS identifies a chemical chaperone for preventing ER protein aggregation and proteotoxicity
      datePublished:2019-12-17
      author:
            type:Person
            name:Keisuke Kitakaze
            type:Person
            name:Shusuke Taniuchi
            type:Person
            name:Eri Kawano
            type:Person
            name:Yoshimasa Hamada
            type:Person
            name:Masato Miyake
            type:Person
            name:Miho Oyadomari
            type:Person
            name:Hirotatsu Kojima
            type:Person
            name:Hidetaka Kosako
            type:Person
            name:Tomoko Kuribara
            type:Person
            name:Suguru Yoshida
            type:Person
            name:Takamitsu Hosoya
            type:Person
            name:Seiichi Oyadomari
      publisher:
         type:Organization
         name:eLife Sciences Publications, Ltd
         logo:
            type:ImageObject
            url:https://elifesciences.org/assets/patterns/img/patterns/organisms/[email protected]
      keywords:
         ER stress
         chemical chaperone
         proteotoxicity
      about:
         Biochemistry and Chemical Biology
         Cell Biology
      description:Cell-based high-throughput screening identifies IBT21 as a chemical chaperone, that inhibits ER protein aggregation and prevents the cell death caused by a proteotoxin, the aggregation-prone prion protein.
      isPartOf:
         type:Periodical
         name:eLife
         issn:2050-084X
WebPage:
      id:https://elifesciences.org/articles/43302
Person:
      name:Keisuke Kitakaze
      name:Shusuke Taniuchi
      name:Eri Kawano
      name:Yoshimasa Hamada
      name:Masato Miyake
      name:Miho Oyadomari
      name:Hirotatsu Kojima
      name:Hidetaka Kosako
      name:Tomoko Kuribara
      name:Suguru Yoshida
      name:Takamitsu Hosoya
      name:Seiichi Oyadomari
Organization:
      name:eLife Sciences Publications, Ltd
      logo:
         type:ImageObject
         url:https://elifesciences.org/assets/patterns/img/patterns/organisms/[email protected]
ImageObject:
      url:https://elifesciences.org/assets/patterns/img/patterns/organisms/[email protected]
Periodical:
      name:eLife
      issn:2050-084X

External Links {πŸ”—}(696)

Analytics and Tracking {πŸ“Š}

  • Google Analytics
  • Google Tag Manager

Libraries {πŸ“š}

  • Highcharts
  • Isotope
  • PhotoSwipe

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {πŸ“¦}

  • Cloudflare
  • Elifesciences
  • Hypothes

4.29s.